Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis ; volume:21 ; number:1 ; day:10 ; month:1 ; year:2020 ; pages:1-10 ; date:12.2020
Respiratory research ; 21, Heft 1 (10.1.2020), 1-10, 12.2020
- Creator
-
Bafadhel, Mona
Singh, Dave
Jenkins, Christine
Peterson, Stefan
Bengtsson, Thomas
Wessman, Peter
Fagerås, Malin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-020-1280-y
- URN
-
urn:nbn:de:101:1-2020041618163772700969
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bafadhel, Mona
- Singh, Dave
- Jenkins, Christine
- Peterson, Stefan
- Bengtsson, Thomas
- Wessman, Peter
- Fagerås, Malin
- SpringerLink (Online service)
Other Objects (12)
COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV1 – a post-hoc analysis of pooled data
Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis
Eosinophil and T cell markers predict functional decline in COPD patients
Blood eosinophil count correlates with alveolar damage in emphysema-predominant COPD
Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
Comparison of glycopyrronium versus tiotropium on the time to clinically important deteriorations in patients with COPD: a post-hoc analysis of randomized trials
Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history
Eosinophil Protein X Concentration Is Dependent on Eosinophil Concentration
ICON: Eosinophil Disorders
Correction to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
COPD in Germany: Use of Diagnostic Measures Including Blood Eosinophil Counts in Daily Practice
COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV1 – a post-hoc analysis of pooled data
Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis
Eosinophil and T cell markers predict functional decline in COPD patients
Blood eosinophil count correlates with alveolar damage in emphysema-predominant COPD
Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
Comparison of glycopyrronium versus tiotropium on the time to clinically important deteriorations in patients with COPD: a post-hoc analysis of randomized trials
Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history
Eosinophil Protein X Concentration Is Dependent on Eosinophil Concentration
ICON: Eosinophil Disorders
Correction to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
COPD in Germany: Use of Diagnostic Measures Including Blood Eosinophil Counts in Daily Practice
COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV1 – a post-hoc analysis of pooled data
Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis
Eosinophil and T cell markers predict functional decline in COPD patients
Blood eosinophil count correlates with alveolar damage in emphysema-predominant COPD
Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
Comparison of glycopyrronium versus tiotropium on the time to clinically important deteriorations in patients with COPD: a post-hoc analysis of randomized trials
Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history
Eosinophil Protein X Concentration Is Dependent on Eosinophil Concentration
ICON: Eosinophil Disorders
Correction to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts